Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.37 USD | +0.15% | -2.80% | -23.98% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.98% | 8.24B | |
-2.60% | 103B | |
+1.70% | 95.28B | |
+1.46% | 22.15B | |
-15.58% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.50% | 16.05B | |
+5.40% | 13.68B | |
+34.44% | 12.17B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma